Showing results (21-30 of 541) with videos related to

Sort By:
Pageof 55
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusionX L Ma, A S Weyrich, S Krantz, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1993
Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusionA M Lefer, X L Ma, A S Weyrich, et al.
The American Journal of Physiology|September 1, 1991
Time course of endothelial dysfunction and myocardial injury during coronary arterial occlusionG E Viehman, X L Ma, D J Lefer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 1991
Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemiaA M Lefer, P S Tsao, D J Lefer, et al.
The American Journal of Physiology|March 1, 1994
Beneficial actions of CP-0127, a novel bradykinin receptor antagonist, in murine traumatic shockT A Christopher, X L Ma, T W Gauthier, et al.
Journal of Molecular and Cellular Cardiology|June 1, 1992
Anti-ischaemic and endothelial protective actions of recombinant human osteogenic protein (hOP-1)A M Lefer, P S Tsao, X L Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1992
Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusionM R Siegfried, J Erhardt, T Rider, et al.
The American Journal of Physiology|August 1, 1991
Protective actions of a leukotriene B4 antagonist in splanchnic ischemia and reperfusion in ratsA Karasawa, J P Guo, X L Ma, et al.
Pageof 55